000 01145cam a2200301 a 4500
005 20250914134252.0
008 040901s2001 xxua b 001 0 eng
020 _a1574911198 (hard)
_cRM1,218.52
039 9 _a200904061039
_bmustaffa
_c200611061106
_dwmeriam
_c200609280917
_druzini
_c200609261510
_druzini
_y09-01-2004
_zfida
060 _aQV771
_b.V172 2001 9
090 _aQV771.V172 2001 9
245 0 0 _aValidation of active pharmaceutical ingredients /
_cIra R. Berry, Daniel Harpaz, editors
250 _a2nd ed.
260 _aDenver, Colo. :
_bIHS Press,
_c2001
300 _axxix, 594 p. :
_bill. ;
_c26 cm.
500 _aLibrary's copy imperfect: p. 589-594 are duplicate index pages
650 2 _aDrug Evaluation
_xstandards
650 2 _aPharmaceutical Preparations
_xanalysis
650 2 _aTechnology, Pharmaceutical
_xstandards
700 1 _aHarpaz, Daniel
700 1 _aBerry, Ira R.,
_d1942-
907 _a.b13425249
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV771.V172 2001 9
914 _avtls003294355
991 _aJabatan Farmasi, KKL
998 _ad
_b2004-01-09
_cm
_da
_feng
_gxxu
_y0
_z.b13425249
999 _c341801
_d341801